SGHC — SGHC Income Statement
0.000.00%
- $4.03bn
- $3.69bn
- €1.70bn
- 93
- 38
- 99
- 91
Annual income statement for SGHC, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 908 | 1,321 | 1,292 | 1,436 | 1,697 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 748 | 1,106 | 1,334 | 1,397 | 1,500 |
Operating Profit | 160 | 215 | -41.6 | 39.2 | 197 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 150 | 226 | 217 | 16.8 | 189 |
Provision for Income Taxes | |||||
Net Income After Taxes | 149 | 236 | 182 | -8.61 | 114 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 149 | 236 | 181 | -10.6 | 113 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 149 | 236 | 181 | -10.6 | 113 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.233 | 0.392 | 0.588 | 0.025 | 0.267 |
Dividends per Share | |||||
Special Dividends per Share |